[SLN] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- -16.95%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 4,765 3,414 -842 122 0 0 385 52.06%
PBT -15,050 -11,227 -3,789 -6,636 -5,370 1,441 -2,410 35.68%
Tax -1,287 -1,793 -1,838 950 507 508 557 -
NP -13,763 -9,434 -1,951 -5,686 -4,862 1,949 -1,854 39.64%
Tax Rate - - - - - -35.30% - -
Total Cost 18,528 12,848 1,109 5,808 4,862 -1,949 2,239 42.19%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -288.84 -276.33 231.71 -4,660.66 0.00 0.00 -481.43 -8.15%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.43 -0.32 -0.07 -0.22 -0.21 0.08 -0.08 32.33%
EPS Diluted -0.43 -0.32 -0.07 -0.22 -0.21 0.08 -0.08 32.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.